Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1
Public ClinicalTrials.gov record NCT05219864. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 (TRuE-CHE1): A Phase 3, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).
Study identification
- NCT ID
- NCT05219864
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2023 (Estimated)
- Primary completion
- Apr 25, 2024 (Estimated)
- Completion
- Sep 22, 2024 (Estimated)
- Last update posted
- Nov 17, 2022
2023 – 2024
United States locations
- U.S. sites
- 26
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Skin Specialists Phoenix Biltmore | Phoenix | Arizona | 85018 | — |
| Raoof Md Encino | Encino | California | 91436 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Marvel Clinical Research Llc | Huntington Beach | California | 92647 | — |
| Well Pharma Medical Research Corporation | Miami | Florida | 33173 | — |
| Psoriasis Treatment Center of South Florida | Pembroke Pines | Florida | 33028 | — |
| Lenus Research Medical Group, Llc | Sweetwater | Florida | 33172 | — |
| Delricht Research | Marietta | Georgia | 30060 | — |
| Arlington Dermatology | Rolling Meadows | Illinois | 60008 | — |
| Midwest Allergy Sinus Asthma, Sc | Springfield | Illinois | 62604 | — |
| Dermatologist Specialist | Louisville | Kentucky | 40241 | — |
| Grafton Dermatology and Cosmetic Surgery | Houma | Louisiana | 70364 | — |
| Delricht Research | New Orleans | Louisiana | 70115 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Jubilee Clinical Research Inc | Las Vegas | Nevada | 89106 | — |
| Juva Skin and Laser Center | New York | New York | 10022 | — |
| Oregon Medical Research Center | Portland | Oregon | 97223 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Clinical Neuroscience Solutions Cns Healthcare Memphis Research Center | Memphis | Tennessee | 38119 | — |
| International Clinical Research Tennessee Llc | Murfreesboro | Tennessee | 37130 | — |
| Austin Institute For Clinical Research Aicr Pflugerville | Houston | Texas | 77056 | — |
| Progressive Clinical Research | San Antonio | Texas | 78213 | — |
| Center For Clinical Studies Webster | Webster | Texas | 77598 | — |
| University of Utah | Murray | Utah | 84107 | — |
| West End Dermatology Associates | Richmond | Virginia | 23233 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05219864, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2022 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05219864 live on ClinicalTrials.gov.